The R&D playbook is evolving as the industry looks to break down the silos between clinical and commercial operations – bringing commercial voices to the earliest phases of asset development.

Read this article by Outsourcing-Pharma that highlights the inaugural 2018 Commericial Trends report by Syneos Health.

This content is repurposed from